Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.

Sever M, Jones TD, Roth LM, Karim FW, Zheng W, Michael H, Hattab EM, Emerson RE, Baldridge LA, Cheng L.

Mod Pathol. 2005 Nov;18(11):1411-6.

2.

Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.

Diniz G, Aktas S, Ortac R, Tunakan M, Unlu I, Vergin C.

Pathol Res Pract. 2006;202(9):671-7. Epub 2006 Jul 24.

PMID:
16860492
3.

Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.

Hersmus R, Stoop H, van de Geijn GJ, Eini R, Biermann K, Oosterhuis JW, Dhooge C, Schneider DT, Meijssen IC, Dinjens WN, Dubbink HJ, Drop SL, Looijenga LH.

PLoS One. 2012;7(8):e43952. doi: 10.1371/journal.pone.0043952. Epub 2012 Aug 28.

4.

Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.

Trinh DT, Shibata K, Hirosawa T, Umezu T, Mizuno M, Kajiyama H, Kikkawa F.

J Obstet Gynaecol Res. 2012 May;38(5):841-8. doi: 10.1111/j.1447-0756.2011.01798.x. Epub 2012 Mar 26.

PMID:
22448662
5.

Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary.

Klein WM, Kurman RJ.

Int J Gynecol Pathol. 2003 Apr;22(2):181-4.

PMID:
12649674
6.

c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study.

Pauls K, Wardelmann E, Merkelbach-Bruse S, Büttner R, Zhou H.

Virchows Arch. 2004 Dec;445(6):651-4. Epub 2004 Sep 29.

PMID:
15455230
7.

OCT4: a novel biomarker for dysgerminoma of the ovary.

Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW.

Am J Surg Pathol. 2004 Oct;28(10):1341-6.

PMID:
15371950
8.

c-Kit is not expressed in malignant mesothelioma.

Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA.

Mod Pathol. 2003 Aug;16(8):818-22.

9.

Cytokeratin and CD30 expression in dysgerminoma.

Cossu-Rocca P, Jones TD, Roth LM, Eble JN, Zheng W, Karim FW, Cheng L.

Hum Pathol. 2006 Aug;37(8):1015-21. Epub 2006 May 26.

PMID:
16867864
10.

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.

Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert-De Meyts E, Lothe RA.

Mol Cancer. 2007 Feb 2;6:12.

11.

C-kit protein expression in Wilms' tumour: an immunohistochemical study.

Giordano G, Campanini N, Rocco A, Donofrio V, Bertolini P, Falleti J, Pettinato G.

Eur J Surg Oncol. 2009 Jun;35(6):629-35. doi: 10.1016/j.ejso.2008.09.014. Epub 2008 Nov 17.

PMID:
19010635
13.

C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.

Auewarakul CU, Lauhakirti D, Promsuwicha O, Munkhetvit C.

Ann Hematol. 2006 Feb;85(2):108-12. Epub 2005 Dec 1.

PMID:
16320053
14.

Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases.

Lifschitz-Mercer B, Walt H, Kushnir I, Jacob N, Diener PA, Moll R, Czernobilsky B.

Hum Pathol. 1995 Jan;26(1):62-6.

PMID:
7821917
15.

c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis.

Medinger M, Kleinschmidt M, Mross K, Wehmeyer B, Unger C, Schaefer HE, Weber R, Azemar M.

Pathol Oncol Res. 2010 Sep;16(3):295-301. doi: 10.1007/s12253-010-9247-9. Epub 2010 Feb 23.

PMID:
20177846
17.

C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.

Kraj M, Pogłód R, Kopeć-Szlezak J, Sokołowska U, Woźniak J, Kruk B.

Leuk Lymphoma. 2004 Nov;45(11):2281-9.

PMID:
15512818
18.

CD117 immunoreactivity in atypical fibroxanthoma.

Mathew RA, Schlauder SM, Calder KB, Morgan MB.

Am J Dermatopathol. 2008 Feb;30(1):34-6. doi: 10.1097/DAD.0b013e31815b8ed5.

PMID:
18212542
19.

Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.

Pauls K, Franke FE, Büttner R, Zhou H.

Virchows Arch. 2005 Sep;447(3):603-9. Epub 2005 Jun 21.

PMID:
15968543
20.

A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.

Espinosa I, Lee CH, Kim MK, Rouse BT, Subramanian S, Montgomery K, Varma S, Corless CL, Heinrich MC, Smith KS, Wang Z, Rubin B, Nielsen TO, Seitz RS, Ross DT, West RB, Cleary ML, van de Rijn M.

Am J Surg Pathol. 2008 Feb;32(2):210-8. doi: 10.1097/PAS.0b013e3181238cec.

PMID:
18223323
Items per page

Supplemental Content

Write to the Help Desk